Physician profile
Casey J Thomas
NPI 1316956212
$800,669.92
in general payments reported to CMS, 2019-2025
5 companies · $61K in 2025
The $61K reported for 2025 was more than what 99% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254K · 2020: $33K · 2021: $95K · 2022: $111K · 2023: $113K · 2024: $133K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $204K · Consulting Fee: $55K · Travel and Lodging: $43K · Food and Beverage: $5,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $204,237.73 |
| Consulting Fee | $54,858.50 |
| Travel and Lodging | $42,641.91 |
| Food and Beverage | $5,071.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $396,307.24 | 2019-2023 | Prevena, V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Allergan, INC. | $161,354.21 | 2019-2022 | |
| Abbvie INC. | $139,663.18 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps, Natrelle Saline-Filled Breast Implants, Botox |
| Solventum Corporation | $103,322.26 | 2024-2025 | Prevena, V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Boston Scientific Corporation | $23.03 | 2024 | Lux-Dx Insertable Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.